A longitudinal study on the effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia

Schizophrenia Research

Volumn 94, Issue 1-3, 2007, Pages 288-292

  Panenka, William J ^a   Khorram, Babak ^a   Barr, Alasdair M ^a   Smith, Geoffrey N ^a   Lang, Donna J ^a   Kopala, Lili C ^b   Vandorpe, Robert A ^b   Honer, William G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antipsychotics; Hippocampus; Longitudinal study; Magnetic resonance imaging; Olanzapine; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; LONGITUDINAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOM;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHRONIC DISEASE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SCHIZOPHRENIA;

EID: 34447098550     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.05.002     Document Type: Article

References (23)

1. Andersson C., Hamer R.M., Lawler C.P., Mailman R.B., and Lieberman J.A. Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology 27 (2002) 143-151
2. Antonova E., Sharma T., Morris R., and Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr. Res. 70 (2004) 117-145
3. Chakos M.H., Schobel S.A., Gu H., Gerig G., Bradford D., Charles C., and Lieberman J.A. Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. Br. J. Psychiatry 186 (2005) 26-31
4. Geuze E., Vermetten E., and Bremner J.D. MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed. Mol. Psychiatry 10 (2005) 147-159
5. Geuze E., Vermetten E., and Bremner J.D. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol. Psychiatry 10 (2005) 160-184
6. Giedd J.N., Vaituzis A.C., Hamburger S.D., Lange N., Rajapakse J.C., Kaysen D., et al. Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4-18 years. J. Comp. Neurol. 366 (1996) 223-230
7. Heckers S., and Konradi C. Hippocampal neurons in schizophrenia. J. Neural Transm. 109 (2002) 891-905
8. Honea R., Crow T.J., Passingham D., and Mackay C.E. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am. J. Psychiatry 162 (2005) 2233-2245
9. Kay S.R., Opler L.A., and Fiszbein A. Positive and Negative Syndrome Scale Manual (1987), Multi-Health Systems, Toronto
10. Khorram B., Lang D.J., Kopala L.C., Vandorpe R.A., Rui Q., Goghari V.M., et al. Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. Am. J. Psychiatry 163 (2006) 2005-2007
11. Kuroki N., Kubicki M., Nestor P.G., Salisbury D.F., Park H.J., Levitt J.J., et al. Fornix integrity and hippocampal volume in male schizophrenic patients. Biol. Psychiatry 60 (2006) 22-31
12. Lang D.J., Kopala L.C., Vandorpe R.A., Rui Q., Smith G.N., Goghari V.M., and Honer W.G. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am. J. Psychiatry 158 (2001) 625-631
13. Lang D.J., Kopala L.C., Vandorpe R.A., Rui Q., Smith G.N., Goghari V.M., et al. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. Am. J. Psychiatry 161 (2004) 1829-1836
14. Lang D.J., Khorram B., Goghari V.M., Kopala L.C., Vandorpe R.A., Rui Q., et al. Reduced anterior internal capsule and thalamic volumes in first-episode psychosis. Schizophr. Res. 87 (2006) 89-99
15. Rajarethinam R., DeQuardo J.R., Miedler J., Arndt S., Kirbat R., Brunberg J.A., and Tandon R. Hippocampus and amygdala in schizophrenia: assessment of the relationship of neuroanatomy to psychopathology. Psychiatry Res. 108 (2001) 79-87
16. Rasband W. NIH Image. 1.62 ed. (1997), National Institutes of Health, Bethesda, MD
17. Roberts G.W. Schizophrenia: the cellular biology of a functional psychosis. Trends Neurosci. 13 (1990) 207-211
18. Scheepers F.E., Gispen de Wied C.C., Hulshoff Pol H.E., and Kahn R.S. Effect of clozapine on caudate nucleus volume in relation to symptoms of schizophrenia. Am. J. Psychiatry 158 (2001) 644-646
19. Scherk H., and Falkai P. Effects of antipsychotics on brain structure. Curr. Opin. Psychiatry 19 (2006) 145-150
20. Tandon R., DeQuardo J.R., Taylor S.F., McGrath M., Jibson M., Eiser A., and Goldman M. Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome. Schizophr. Res. 45 (2000) 191-201
21. Tata D.A., Marciano V.A., and Anderson B.J. Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3. J. Comp. Neurol. 498 (2006) 363-374
22. Velakoulis D., Wood S.J., Wong M.T., McGorry P.D., Yung A., Phillips L., et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch. Gen. Psychiatry 63 (2006) 139-149
23. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., and Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry 157 (2000) 16-25